Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkae037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Malgorzata Mikulska und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Health Sciences, University of Genova, Genova, Italy. Hauptthemen laut MEDLINE: Drug Monitoring, Critical Illness, Nitriles, Pyridines. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
Isavuconazole is first-line treatment of invasive aspergillosis. Therapeutic drug monitoring (TDM) is deemed not necessary, since most patients reached therapeutic levels (>1 mg/L) in large studies. Low levels were reported in some critically ill patients admitted to the ICU. The aim was to compare isavuconazole levels between critically ill and non-critically ill patients. Materials and methods Retrospective analysis of data from all patients treated with standard-dose isavuconazole between 1 January 2019 and 26 October 2022 was performed. The following data were collected: TDM results from the first 30 days of therapy; ward of admission; demographic and clinical characteristics; continuous renal replacement therapy; extracorporeal membrane oxygenation; and co-administered drugs.
Results
Seventy-two patients (median age 65 years) and 188 TDM measurements (mean number of samples per patient 2.6 ± 1.7) were included; 33 (45.8%) were ICU patients (3 also had haematological disorders); 39 (54.2%) were non-ICU patients, of whom 31 had haematological disorders. In all patients, the mean isavuconazole blood level was 3.33 ± 2.26 mg/L. Significantly lower levels were observed in the ICU versus the non-ICU population: mean 2.02 ± 1.22 versus 4.15 ± 2.31 mg/L (P < 0.001). Significantly higher rates of subtherapeutic levels were observed in ICU patients compared with the non-ICU population: all determinations <2 mg/L in 33.3% versus 7.7%, and all determinations <1 mg/L in 12.1% versus 0%, respectively. Predictors of lower isavuconazole levels were admission to the ICU, BMI > 25 kg/m2, bilirubin > 1.2 mg/dL and the absence of haematological disorder.
Conclusions
ICU patients had significantly lower isavuconazole blood levels compared to non-ICU population. The TDM of isavuconazole for efficacy should be performed in ICU.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Health Sciences, University of Genova, Genova, Italy.
- Division of Infectious Diseases, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
- Department of Health Sciences, Section of Biostatistics, University of Genoa, Genova, Italy.
- Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
- Anesthesia and Intensive Care, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
- Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genova, Italy.
ORCID-Profile: Malgorzata Mikulska, Chiara Sepulcri, Daniele Roberto Giacobbe, Chiara Dentone, Chiara Robba
Zitieren
APA
Mikulska, M., Melchio, M., Signori, A., Ullah, N., Miletich, F., Sepulcri, C., Limongelli, A., Giacobbe, D. R., Balletto, E., Russo, C., Magnasco, L., Vena, A., Di Grazia, C., Raiola, A. M., Portunato, F., Dentone, C., Battaglini, D., Ball, L., Robba, C., …, & Bassetti, M. (2024). Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae037
Vancouver
Mikulska M, Melchio M, Signori A, Ullah N, Miletich F, Sepulcri C, et al. Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae037
BibTeX
@article{Mikulska2024,
author = {Mikulska, Malgorzata and Melchio, Monica and Signori, Alessio and Ullah, Nadir and Miletich, Franca and Sepulcri, Chiara and Limongelli, Alessandro and Giacobbe, Daniele Roberto and Balletto, Elisa and Russo, Chiara and Magnasco, Laura and Vena, Antonio and Di Grazia, Carmen and Raiola, Anna Maria and Portunato, Federica and Dentone, Chiara and Battaglini, Denise and Ball, Lorenzo and Robba, Chiara and Angelucci, Emanuele and Brunetti, Iole and Bassetti, Matteo},
title = {Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkae037}
}
EUVIMED